Review



nr2c2  (Santa Cruz Biotechnology)


Bioz Verified Symbol Santa Cruz Biotechnology is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    Santa Cruz Biotechnology nr2c2
    Nr2c2, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 15 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/nr2c2/TR4+Antibody/pmc12477713-123-16-19
    Average 93 stars, based on 15 article reviews
    nr2c2 - by Bioz Stars, 2026-10
    93/100 stars

    Images

    Related Articles

    Western Blot:

    Article Title: Mapping the FOXA1 Interactome in ER+ Breast Cancer Cells using Proximity Labeling Reveals Novel Interactions with the Orphan Nuclear Receptor NR2C2
    Article Snippet: .. The antibodies for the western blot related to the coimmunoprecipitation are FOXA1 (0.3μg/mL) (Abcam, Ab5089) and NR2C2 (1:500 dilution) (Santa Cruz Biotechonology, sc-365895, RRID: AB_10844760). .. The secondary antibodies are: anti-mouse IgG (H+L) secondary antibody, HRP (1:10000) (Invitrogen, PA1–28748, RRID:AB_10982166) and anti-goat HRP (1:7500) (Abcam, A15999, RRID:AB_2534673).



    Similar Products

    93
    Cyagen Biosciences nr2c2 gene knockout mice
    Nr2c2 Gene Knockout Mice, supplied by Cyagen Biosciences, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/nr2c2/Nr2c2/pm41317934-51-1-8
    Average 93 stars, based on 1 article reviews
    nr2c2 gene knockout mice - by Bioz Stars, 2026-10
    93/100 stars
      Buy from Supplier

    93
    ABclonal Biotechnology anti nr2c2 antibody
    Anti Nr2c2 Antibody, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/nr2c2/NR2C2+Rabbit+pAb/pm41317934-126-8-10
    Average 93 stars, based on 1 article reviews
    anti nr2c2 antibody - by Bioz Stars, 2026-10
    93/100 stars
      Buy from Supplier

    93
    OriGene nr2c2 nm 003298 human tagged orf
    (A) Volcano plot of m 6 A-IP-seq targets in shALKBH1 #1 As-Tr cells with <t>NR2C2</t> as a top target labeled (black arrow). (B) HOMER motif analysis demonstrating the canonical m 6 A GGACU motif is enriched across experimental samples. (C) IGV visualization of increased m 6 A enrichment on representative site on the NR2C2 transcript. (D) qPCR analysis of the m 6 A levels on the NR2C2 transcript following m 6 A-IP in shNC and shALKBH1 #1 As-Tr cells. (E) qPCR analysis of the m 6 A levels on the NR2C2 transcript following m 6 A-IP of HaCaT control cells without or without 200 nM arsenic for 72 h and As-Tr cells. (F) CLIP-qPCR analysis of FLAG (ALKBH1) binding to sites on the NR2C2 transcript ( NM_001291694.2 , site 1: regions 1508243–1504892, and site 2: 150486–15048792, respectively) with an anti-FLAG or immunoglobulin G (IgG) antibody in shALKBH1 #1 As-Tr cells transfected with a construct expressing ALKBH1 (FLAG). (G) Immunoblot analysis of NR2C2 in shNC and shALKBH1 #1 As-Tr cells. (H) RT-qPCR of NR2C2 mRNA levels in shNC and shALKBH1 #1 As-Tr cells. (I) Immunoblot analysis of NR2C2 expression in HaCaT and A431 SCC cells. (J) Immunoblot analysis of NR2C2 expression in control (no As) and As-Tr cells. (K) Immunoblot analysis of NR2C2 expression in HaCaT cells treated with 200 nM arsenic for 72 h. (L) Immunoblot analysis of HA and NR2C2 expression in shALKBH1 #1 As-Tr cells expressing empty vector (EV), WT ALKBH1, catalytically inactive mutant ALKBH1 (D233A), and C118A and C207A mutant ALKBH1. (M) Immunoblot analysis of METTL3, METTL14, and NR2C2 expression in shALKBH1 #1 As-Tr cells transfected with control or METTL3/METTL14 siRNA. (N) Immunoblot analysis of YTHDF1 and NR2C2 expression in shALKBH1 #1 As-Tr cells transfected with control or YTHDF1 siRNA. (O) RNA immunoprecipitation (RIP) and qPCR analysis showing the binding of YTHDF1 to the NR2C2 transcript in As-Tr cells. (P) CCK8 assay of shALKBH1 #1 As-Tr cells with or without NR2C2 knockout. (Q) Soft agar cloning assay of shALKBH1 #1 As-Tr cells with or without NR2C2 knockout. (R) CCK8 assay of As-Tr cells with or without NR2C2 overexpression. (S) Soft agar cloning assay of As-Tr cells with or without NR2C2 overexpression. * p < 0.05; ** p < 0.01; *** p < 0.001; Student’s t test.
    Nr2c2 Nm 003298 Human Tagged Orf, supplied by OriGene, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/nr2c2/NR2C2+(NM_003298)+Human+Tagged+ORF+Clone/pmc12696649-106-0-9
    Average 93 stars, based on 1 article reviews
    nr2c2 nm 003298 human tagged orf - by Bioz Stars, 2026-10
    93/100 stars
      Buy from Supplier

    93
    Cell Signaling Technology Inc perk t202 t204
    (A) Volcano plot of m 6 A-IP-seq targets in shALKBH1 #1 As-Tr cells with <t>NR2C2</t> as a top target labeled (black arrow). (B) HOMER motif analysis demonstrating the canonical m 6 A GGACU motif is enriched across experimental samples. (C) IGV visualization of increased m 6 A enrichment on representative site on the NR2C2 transcript. (D) qPCR analysis of the m 6 A levels on the NR2C2 transcript following m 6 A-IP in shNC and shALKBH1 #1 As-Tr cells. (E) qPCR analysis of the m 6 A levels on the NR2C2 transcript following m 6 A-IP of HaCaT control cells without or without 200 nM arsenic for 72 h and As-Tr cells. (F) CLIP-qPCR analysis of FLAG (ALKBH1) binding to sites on the NR2C2 transcript ( NM_001291694.2 , site 1: regions 1508243–1504892, and site 2: 150486–15048792, respectively) with an anti-FLAG or immunoglobulin G (IgG) antibody in shALKBH1 #1 As-Tr cells transfected with a construct expressing ALKBH1 (FLAG). (G) Immunoblot analysis of NR2C2 in shNC and shALKBH1 #1 As-Tr cells. (H) RT-qPCR of NR2C2 mRNA levels in shNC and shALKBH1 #1 As-Tr cells. (I) Immunoblot analysis of NR2C2 expression in HaCaT and A431 SCC cells. (J) Immunoblot analysis of NR2C2 expression in control (no As) and As-Tr cells. (K) Immunoblot analysis of NR2C2 expression in HaCaT cells treated with 200 nM arsenic for 72 h. (L) Immunoblot analysis of HA and NR2C2 expression in shALKBH1 #1 As-Tr cells expressing empty vector (EV), WT ALKBH1, catalytically inactive mutant ALKBH1 (D233A), and C118A and C207A mutant ALKBH1. (M) Immunoblot analysis of METTL3, METTL14, and NR2C2 expression in shALKBH1 #1 As-Tr cells transfected with control or METTL3/METTL14 siRNA. (N) Immunoblot analysis of YTHDF1 and NR2C2 expression in shALKBH1 #1 As-Tr cells transfected with control or YTHDF1 siRNA. (O) RNA immunoprecipitation (RIP) and qPCR analysis showing the binding of YTHDF1 to the NR2C2 transcript in As-Tr cells. (P) CCK8 assay of shALKBH1 #1 As-Tr cells with or without NR2C2 knockout. (Q) Soft agar cloning assay of shALKBH1 #1 As-Tr cells with or without NR2C2 knockout. (R) CCK8 assay of As-Tr cells with or without NR2C2 overexpression. (S) Soft agar cloning assay of As-Tr cells with or without NR2C2 overexpression. * p < 0.05; ** p < 0.01; *** p < 0.001; Student’s t test.
    Perk T202 T204, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/nr2c2/TR4%2FNR2C2+Rabbit+mAb/10__1158_slash_1078___0432__ccr___25___1459-138-62-118
    Average 93 stars, based on 1 article reviews
    perk t202 t204 - by Bioz Stars, 2026-10
    93/100 stars
      Buy from Supplier

    93
    Santa Cruz Biotechnology nr2c2
    (A) Volcano plot of m 6 A-IP-seq targets in shALKBH1 #1 As-Tr cells with <t>NR2C2</t> as a top target labeled (black arrow). (B) HOMER motif analysis demonstrating the canonical m 6 A GGACU motif is enriched across experimental samples. (C) IGV visualization of increased m 6 A enrichment on representative site on the NR2C2 transcript. (D) qPCR analysis of the m 6 A levels on the NR2C2 transcript following m 6 A-IP in shNC and shALKBH1 #1 As-Tr cells. (E) qPCR analysis of the m 6 A levels on the NR2C2 transcript following m 6 A-IP of HaCaT control cells without or without 200 nM arsenic for 72 h and As-Tr cells. (F) CLIP-qPCR analysis of FLAG (ALKBH1) binding to sites on the NR2C2 transcript ( NM_001291694.2 , site 1: regions 1508243–1504892, and site 2: 150486–15048792, respectively) with an anti-FLAG or immunoglobulin G (IgG) antibody in shALKBH1 #1 As-Tr cells transfected with a construct expressing ALKBH1 (FLAG). (G) Immunoblot analysis of NR2C2 in shNC and shALKBH1 #1 As-Tr cells. (H) RT-qPCR of NR2C2 mRNA levels in shNC and shALKBH1 #1 As-Tr cells. (I) Immunoblot analysis of NR2C2 expression in HaCaT and A431 SCC cells. (J) Immunoblot analysis of NR2C2 expression in control (no As) and As-Tr cells. (K) Immunoblot analysis of NR2C2 expression in HaCaT cells treated with 200 nM arsenic for 72 h. (L) Immunoblot analysis of HA and NR2C2 expression in shALKBH1 #1 As-Tr cells expressing empty vector (EV), WT ALKBH1, catalytically inactive mutant ALKBH1 (D233A), and C118A and C207A mutant ALKBH1. (M) Immunoblot analysis of METTL3, METTL14, and NR2C2 expression in shALKBH1 #1 As-Tr cells transfected with control or METTL3/METTL14 siRNA. (N) Immunoblot analysis of YTHDF1 and NR2C2 expression in shALKBH1 #1 As-Tr cells transfected with control or YTHDF1 siRNA. (O) RNA immunoprecipitation (RIP) and qPCR analysis showing the binding of YTHDF1 to the NR2C2 transcript in As-Tr cells. (P) CCK8 assay of shALKBH1 #1 As-Tr cells with or without NR2C2 knockout. (Q) Soft agar cloning assay of shALKBH1 #1 As-Tr cells with or without NR2C2 knockout. (R) CCK8 assay of As-Tr cells with or without NR2C2 overexpression. (S) Soft agar cloning assay of As-Tr cells with or without NR2C2 overexpression. * p < 0.05; ** p < 0.01; *** p < 0.001; Student’s t test.
    Nr2c2, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/nr2c2/TR4+Antibody/pmc12477713-123-16-19
    Average 93 stars, based on 1 article reviews
    nr2c2 - by Bioz Stars, 2026-10
    93/100 stars
      Buy from Supplier

    93
    Boster Bio anti tak1
    (A) Volcano plot of m 6 A-IP-seq targets in shALKBH1 #1 As-Tr cells with <t>NR2C2</t> as a top target labeled (black arrow). (B) HOMER motif analysis demonstrating the canonical m 6 A GGACU motif is enriched across experimental samples. (C) IGV visualization of increased m 6 A enrichment on representative site on the NR2C2 transcript. (D) qPCR analysis of the m 6 A levels on the NR2C2 transcript following m 6 A-IP in shNC and shALKBH1 #1 As-Tr cells. (E) qPCR analysis of the m 6 A levels on the NR2C2 transcript following m 6 A-IP of HaCaT control cells without or without 200 nM arsenic for 72 h and As-Tr cells. (F) CLIP-qPCR analysis of FLAG (ALKBH1) binding to sites on the NR2C2 transcript ( NM_001291694.2 , site 1: regions 1508243–1504892, and site 2: 150486–15048792, respectively) with an anti-FLAG or immunoglobulin G (IgG) antibody in shALKBH1 #1 As-Tr cells transfected with a construct expressing ALKBH1 (FLAG). (G) Immunoblot analysis of NR2C2 in shNC and shALKBH1 #1 As-Tr cells. (H) RT-qPCR of NR2C2 mRNA levels in shNC and shALKBH1 #1 As-Tr cells. (I) Immunoblot analysis of NR2C2 expression in HaCaT and A431 SCC cells. (J) Immunoblot analysis of NR2C2 expression in control (no As) and As-Tr cells. (K) Immunoblot analysis of NR2C2 expression in HaCaT cells treated with 200 nM arsenic for 72 h. (L) Immunoblot analysis of HA and NR2C2 expression in shALKBH1 #1 As-Tr cells expressing empty vector (EV), WT ALKBH1, catalytically inactive mutant ALKBH1 (D233A), and C118A and C207A mutant ALKBH1. (M) Immunoblot analysis of METTL3, METTL14, and NR2C2 expression in shALKBH1 #1 As-Tr cells transfected with control or METTL3/METTL14 siRNA. (N) Immunoblot analysis of YTHDF1 and NR2C2 expression in shALKBH1 #1 As-Tr cells transfected with control or YTHDF1 siRNA. (O) RNA immunoprecipitation (RIP) and qPCR analysis showing the binding of YTHDF1 to the NR2C2 transcript in As-Tr cells. (P) CCK8 assay of shALKBH1 #1 As-Tr cells with or without NR2C2 knockout. (Q) Soft agar cloning assay of shALKBH1 #1 As-Tr cells with or without NR2C2 knockout. (R) CCK8 assay of As-Tr cells with or without NR2C2 overexpression. (S) Soft agar cloning assay of As-Tr cells with or without NR2C2 overexpression. * p < 0.05; ** p < 0.01; *** p < 0.001; Student’s t test.
    Anti Tak1, supplied by Boster Bio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/nr2c2/Anti-NR2C2+Antibody/pm40701449-102-22-25
    Average 93 stars, based on 1 article reviews
    anti tak1 - by Bioz Stars, 2026-10
    93/100 stars
      Buy from Supplier

    93
    Cell Signaling Technology Inc anti nr2c2
    (A) Volcano plot of m 6 A-IP-seq targets in shALKBH1 #1 As-Tr cells with <t>NR2C2</t> as a top target labeled (black arrow). (B) HOMER motif analysis demonstrating the canonical m 6 A GGACU motif is enriched across experimental samples. (C) IGV visualization of increased m 6 A enrichment on representative site on the NR2C2 transcript. (D) qPCR analysis of the m 6 A levels on the NR2C2 transcript following m 6 A-IP in shNC and shALKBH1 #1 As-Tr cells. (E) qPCR analysis of the m 6 A levels on the NR2C2 transcript following m 6 A-IP of HaCaT control cells without or without 200 nM arsenic for 72 h and As-Tr cells. (F) CLIP-qPCR analysis of FLAG (ALKBH1) binding to sites on the NR2C2 transcript ( NM_001291694.2 , site 1: regions 1508243–1504892, and site 2: 150486–15048792, respectively) with an anti-FLAG or immunoglobulin G (IgG) antibody in shALKBH1 #1 As-Tr cells transfected with a construct expressing ALKBH1 (FLAG). (G) Immunoblot analysis of NR2C2 in shNC and shALKBH1 #1 As-Tr cells. (H) RT-qPCR of NR2C2 mRNA levels in shNC and shALKBH1 #1 As-Tr cells. (I) Immunoblot analysis of NR2C2 expression in HaCaT and A431 SCC cells. (J) Immunoblot analysis of NR2C2 expression in control (no As) and As-Tr cells. (K) Immunoblot analysis of NR2C2 expression in HaCaT cells treated with 200 nM arsenic for 72 h. (L) Immunoblot analysis of HA and NR2C2 expression in shALKBH1 #1 As-Tr cells expressing empty vector (EV), WT ALKBH1, catalytically inactive mutant ALKBH1 (D233A), and C118A and C207A mutant ALKBH1. (M) Immunoblot analysis of METTL3, METTL14, and NR2C2 expression in shALKBH1 #1 As-Tr cells transfected with control or METTL3/METTL14 siRNA. (N) Immunoblot analysis of YTHDF1 and NR2C2 expression in shALKBH1 #1 As-Tr cells transfected with control or YTHDF1 siRNA. (O) RNA immunoprecipitation (RIP) and qPCR analysis showing the binding of YTHDF1 to the NR2C2 transcript in As-Tr cells. (P) CCK8 assay of shALKBH1 #1 As-Tr cells with or without NR2C2 knockout. (Q) Soft agar cloning assay of shALKBH1 #1 As-Tr cells with or without NR2C2 knockout. (R) CCK8 assay of As-Tr cells with or without NR2C2 overexpression. (S) Soft agar cloning assay of As-Tr cells with or without NR2C2 overexpression. * p < 0.05; ** p < 0.01; *** p < 0.001; Student’s t test.
    Anti Nr2c2, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/nr2c2/TR4%2FNR2C2+Rabbit+mAb/pmc11244937__media___1-402-58-59
    Average 93 stars, based on 1 article reviews
    anti nr2c2 - by Bioz Stars, 2026-10
    93/100 stars
      Buy from Supplier

    93
    Addgene inc pax5 nr2c2 interactions
    (A) Volcano plot of m 6 A-IP-seq targets in shALKBH1 #1 As-Tr cells with <t>NR2C2</t> as a top target labeled (black arrow). (B) HOMER motif analysis demonstrating the canonical m 6 A GGACU motif is enriched across experimental samples. (C) IGV visualization of increased m 6 A enrichment on representative site on the NR2C2 transcript. (D) qPCR analysis of the m 6 A levels on the NR2C2 transcript following m 6 A-IP in shNC and shALKBH1 #1 As-Tr cells. (E) qPCR analysis of the m 6 A levels on the NR2C2 transcript following m 6 A-IP of HaCaT control cells without or without 200 nM arsenic for 72 h and As-Tr cells. (F) CLIP-qPCR analysis of FLAG (ALKBH1) binding to sites on the NR2C2 transcript ( NM_001291694.2 , site 1: regions 1508243–1504892, and site 2: 150486–15048792, respectively) with an anti-FLAG or immunoglobulin G (IgG) antibody in shALKBH1 #1 As-Tr cells transfected with a construct expressing ALKBH1 (FLAG). (G) Immunoblot analysis of NR2C2 in shNC and shALKBH1 #1 As-Tr cells. (H) RT-qPCR of NR2C2 mRNA levels in shNC and shALKBH1 #1 As-Tr cells. (I) Immunoblot analysis of NR2C2 expression in HaCaT and A431 SCC cells. (J) Immunoblot analysis of NR2C2 expression in control (no As) and As-Tr cells. (K) Immunoblot analysis of NR2C2 expression in HaCaT cells treated with 200 nM arsenic for 72 h. (L) Immunoblot analysis of HA and NR2C2 expression in shALKBH1 #1 As-Tr cells expressing empty vector (EV), WT ALKBH1, catalytically inactive mutant ALKBH1 (D233A), and C118A and C207A mutant ALKBH1. (M) Immunoblot analysis of METTL3, METTL14, and NR2C2 expression in shALKBH1 #1 As-Tr cells transfected with control or METTL3/METTL14 siRNA. (N) Immunoblot analysis of YTHDF1 and NR2C2 expression in shALKBH1 #1 As-Tr cells transfected with control or YTHDF1 siRNA. (O) RNA immunoprecipitation (RIP) and qPCR analysis showing the binding of YTHDF1 to the NR2C2 transcript in As-Tr cells. (P) CCK8 assay of shALKBH1 #1 As-Tr cells with or without NR2C2 knockout. (Q) Soft agar cloning assay of shALKBH1 #1 As-Tr cells with or without NR2C2 knockout. (R) CCK8 assay of As-Tr cells with or without NR2C2 overexpression. (S) Soft agar cloning assay of As-Tr cells with or without NR2C2 overexpression. * p < 0.05; ** p < 0.01; *** p < 0.001; Student’s t test.
    Pax5 Nr2c2 Interactions, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/nr2c2/Pax5+(Plasmid+%2335003)/pmc11244937__media___1-393-5-21
    Average 93 stars, based on 1 article reviews
    pax5 nr2c2 interactions - by Bioz Stars, 2026-10
    93/100 stars
      Buy from Supplier

    93
    R&D Systems anti tr4
    (A) Volcano plot of m 6 A-IP-seq targets in shALKBH1 #1 As-Tr cells with <t>NR2C2</t> as a top target labeled (black arrow). (B) HOMER motif analysis demonstrating the canonical m 6 A GGACU motif is enriched across experimental samples. (C) IGV visualization of increased m 6 A enrichment on representative site on the NR2C2 transcript. (D) qPCR analysis of the m 6 A levels on the NR2C2 transcript following m 6 A-IP in shNC and shALKBH1 #1 As-Tr cells. (E) qPCR analysis of the m 6 A levels on the NR2C2 transcript following m 6 A-IP of HaCaT control cells without or without 200 nM arsenic for 72 h and As-Tr cells. (F) CLIP-qPCR analysis of FLAG (ALKBH1) binding to sites on the NR2C2 transcript ( NM_001291694.2 , site 1: regions 1508243–1504892, and site 2: 150486–15048792, respectively) with an anti-FLAG or immunoglobulin G (IgG) antibody in shALKBH1 #1 As-Tr cells transfected with a construct expressing ALKBH1 (FLAG). (G) Immunoblot analysis of NR2C2 in shNC and shALKBH1 #1 As-Tr cells. (H) RT-qPCR of NR2C2 mRNA levels in shNC and shALKBH1 #1 As-Tr cells. (I) Immunoblot analysis of NR2C2 expression in HaCaT and A431 SCC cells. (J) Immunoblot analysis of NR2C2 expression in control (no As) and As-Tr cells. (K) Immunoblot analysis of NR2C2 expression in HaCaT cells treated with 200 nM arsenic for 72 h. (L) Immunoblot analysis of HA and NR2C2 expression in shALKBH1 #1 As-Tr cells expressing empty vector (EV), WT ALKBH1, catalytically inactive mutant ALKBH1 (D233A), and C118A and C207A mutant ALKBH1. (M) Immunoblot analysis of METTL3, METTL14, and NR2C2 expression in shALKBH1 #1 As-Tr cells transfected with control or METTL3/METTL14 siRNA. (N) Immunoblot analysis of YTHDF1 and NR2C2 expression in shALKBH1 #1 As-Tr cells transfected with control or YTHDF1 siRNA. (O) RNA immunoprecipitation (RIP) and qPCR analysis showing the binding of YTHDF1 to the NR2C2 transcript in As-Tr cells. (P) CCK8 assay of shALKBH1 #1 As-Tr cells with or without NR2C2 knockout. (Q) Soft agar cloning assay of shALKBH1 #1 As-Tr cells with or without NR2C2 knockout. (R) CCK8 assay of As-Tr cells with or without NR2C2 overexpression. (S) Soft agar cloning assay of As-Tr cells with or without NR2C2 overexpression. * p < 0.05; ** p < 0.01; *** p < 0.001; Student’s t test.
    Anti Tr4, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/nr2c2/Human+TR4%2FNR2C2+Antibody/bio_rxiv__2025__06__16__658187-186-9-11
    Average 93 stars, based on 1 article reviews
    anti tr4 - by Bioz Stars, 2026-10
    93/100 stars
      Buy from Supplier

    93
    ABclonal Biotechnology nr2c2
    (A) Volcano plot of m 6 A-IP-seq targets in shALKBH1 #1 As-Tr cells with <t>NR2C2</t> as a top target labeled (black arrow). (B) HOMER motif analysis demonstrating the canonical m 6 A GGACU motif is enriched across experimental samples. (C) IGV visualization of increased m 6 A enrichment on representative site on the NR2C2 transcript. (D) qPCR analysis of the m 6 A levels on the NR2C2 transcript following m 6 A-IP in shNC and shALKBH1 #1 As-Tr cells. (E) qPCR analysis of the m 6 A levels on the NR2C2 transcript following m 6 A-IP of HaCaT control cells without or without 200 nM arsenic for 72 h and As-Tr cells. (F) CLIP-qPCR analysis of FLAG (ALKBH1) binding to sites on the NR2C2 transcript ( NM_001291694.2 , site 1: regions 1508243–1504892, and site 2: 150486–15048792, respectively) with an anti-FLAG or immunoglobulin G (IgG) antibody in shALKBH1 #1 As-Tr cells transfected with a construct expressing ALKBH1 (FLAG). (G) Immunoblot analysis of NR2C2 in shNC and shALKBH1 #1 As-Tr cells. (H) RT-qPCR of NR2C2 mRNA levels in shNC and shALKBH1 #1 As-Tr cells. (I) Immunoblot analysis of NR2C2 expression in HaCaT and A431 SCC cells. (J) Immunoblot analysis of NR2C2 expression in control (no As) and As-Tr cells. (K) Immunoblot analysis of NR2C2 expression in HaCaT cells treated with 200 nM arsenic for 72 h. (L) Immunoblot analysis of HA and NR2C2 expression in shALKBH1 #1 As-Tr cells expressing empty vector (EV), WT ALKBH1, catalytically inactive mutant ALKBH1 (D233A), and C118A and C207A mutant ALKBH1. (M) Immunoblot analysis of METTL3, METTL14, and NR2C2 expression in shALKBH1 #1 As-Tr cells transfected with control or METTL3/METTL14 siRNA. (N) Immunoblot analysis of YTHDF1 and NR2C2 expression in shALKBH1 #1 As-Tr cells transfected with control or YTHDF1 siRNA. (O) RNA immunoprecipitation (RIP) and qPCR analysis showing the binding of YTHDF1 to the NR2C2 transcript in As-Tr cells. (P) CCK8 assay of shALKBH1 #1 As-Tr cells with or without NR2C2 knockout. (Q) Soft agar cloning assay of shALKBH1 #1 As-Tr cells with or without NR2C2 knockout. (R) CCK8 assay of As-Tr cells with or without NR2C2 overexpression. (S) Soft agar cloning assay of As-Tr cells with or without NR2C2 overexpression. * p < 0.05; ** p < 0.01; *** p < 0.001; Student’s t test.
    Nr2c2, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/nr2c2/NR2C2+Rabbit+pAb/pm40199774-71-82-83
    Average 93 stars, based on 1 article reviews
    nr2c2 - by Bioz Stars, 2026-10
    93/100 stars
      Buy from Supplier

    Image Search Results


    (A) Volcano plot of m 6 A-IP-seq targets in shALKBH1 #1 As-Tr cells with NR2C2 as a top target labeled (black arrow). (B) HOMER motif analysis demonstrating the canonical m 6 A GGACU motif is enriched across experimental samples. (C) IGV visualization of increased m 6 A enrichment on representative site on the NR2C2 transcript. (D) qPCR analysis of the m 6 A levels on the NR2C2 transcript following m 6 A-IP in shNC and shALKBH1 #1 As-Tr cells. (E) qPCR analysis of the m 6 A levels on the NR2C2 transcript following m 6 A-IP of HaCaT control cells without or without 200 nM arsenic for 72 h and As-Tr cells. (F) CLIP-qPCR analysis of FLAG (ALKBH1) binding to sites on the NR2C2 transcript ( NM_001291694.2 , site 1: regions 1508243–1504892, and site 2: 150486–15048792, respectively) with an anti-FLAG or immunoglobulin G (IgG) antibody in shALKBH1 #1 As-Tr cells transfected with a construct expressing ALKBH1 (FLAG). (G) Immunoblot analysis of NR2C2 in shNC and shALKBH1 #1 As-Tr cells. (H) RT-qPCR of NR2C2 mRNA levels in shNC and shALKBH1 #1 As-Tr cells. (I) Immunoblot analysis of NR2C2 expression in HaCaT and A431 SCC cells. (J) Immunoblot analysis of NR2C2 expression in control (no As) and As-Tr cells. (K) Immunoblot analysis of NR2C2 expression in HaCaT cells treated with 200 nM arsenic for 72 h. (L) Immunoblot analysis of HA and NR2C2 expression in shALKBH1 #1 As-Tr cells expressing empty vector (EV), WT ALKBH1, catalytically inactive mutant ALKBH1 (D233A), and C118A and C207A mutant ALKBH1. (M) Immunoblot analysis of METTL3, METTL14, and NR2C2 expression in shALKBH1 #1 As-Tr cells transfected with control or METTL3/METTL14 siRNA. (N) Immunoblot analysis of YTHDF1 and NR2C2 expression in shALKBH1 #1 As-Tr cells transfected with control or YTHDF1 siRNA. (O) RNA immunoprecipitation (RIP) and qPCR analysis showing the binding of YTHDF1 to the NR2C2 transcript in As-Tr cells. (P) CCK8 assay of shALKBH1 #1 As-Tr cells with or without NR2C2 knockout. (Q) Soft agar cloning assay of shALKBH1 #1 As-Tr cells with or without NR2C2 knockout. (R) CCK8 assay of As-Tr cells with or without NR2C2 overexpression. (S) Soft agar cloning assay of As-Tr cells with or without NR2C2 overexpression. * p < 0.05; ** p < 0.01; *** p < 0.001; Student’s t test.

    Journal: Cell reports

    Article Title: Arsenic regulates ALKBH1 abundance and substrate specificity to promote translation and tumorigenicity

    doi: 10.1016/j.celrep.2025.116311

    Figure Lengend Snippet: (A) Volcano plot of m 6 A-IP-seq targets in shALKBH1 #1 As-Tr cells with NR2C2 as a top target labeled (black arrow). (B) HOMER motif analysis demonstrating the canonical m 6 A GGACU motif is enriched across experimental samples. (C) IGV visualization of increased m 6 A enrichment on representative site on the NR2C2 transcript. (D) qPCR analysis of the m 6 A levels on the NR2C2 transcript following m 6 A-IP in shNC and shALKBH1 #1 As-Tr cells. (E) qPCR analysis of the m 6 A levels on the NR2C2 transcript following m 6 A-IP of HaCaT control cells without or without 200 nM arsenic for 72 h and As-Tr cells. (F) CLIP-qPCR analysis of FLAG (ALKBH1) binding to sites on the NR2C2 transcript ( NM_001291694.2 , site 1: regions 1508243–1504892, and site 2: 150486–15048792, respectively) with an anti-FLAG or immunoglobulin G (IgG) antibody in shALKBH1 #1 As-Tr cells transfected with a construct expressing ALKBH1 (FLAG). (G) Immunoblot analysis of NR2C2 in shNC and shALKBH1 #1 As-Tr cells. (H) RT-qPCR of NR2C2 mRNA levels in shNC and shALKBH1 #1 As-Tr cells. (I) Immunoblot analysis of NR2C2 expression in HaCaT and A431 SCC cells. (J) Immunoblot analysis of NR2C2 expression in control (no As) and As-Tr cells. (K) Immunoblot analysis of NR2C2 expression in HaCaT cells treated with 200 nM arsenic for 72 h. (L) Immunoblot analysis of HA and NR2C2 expression in shALKBH1 #1 As-Tr cells expressing empty vector (EV), WT ALKBH1, catalytically inactive mutant ALKBH1 (D233A), and C118A and C207A mutant ALKBH1. (M) Immunoblot analysis of METTL3, METTL14, and NR2C2 expression in shALKBH1 #1 As-Tr cells transfected with control or METTL3/METTL14 siRNA. (N) Immunoblot analysis of YTHDF1 and NR2C2 expression in shALKBH1 #1 As-Tr cells transfected with control or YTHDF1 siRNA. (O) RNA immunoprecipitation (RIP) and qPCR analysis showing the binding of YTHDF1 to the NR2C2 transcript in As-Tr cells. (P) CCK8 assay of shALKBH1 #1 As-Tr cells with or without NR2C2 knockout. (Q) Soft agar cloning assay of shALKBH1 #1 As-Tr cells with or without NR2C2 knockout. (R) CCK8 assay of As-Tr cells with or without NR2C2 overexpression. (S) Soft agar cloning assay of As-Tr cells with or without NR2C2 overexpression. * p < 0.05; ** p < 0.01; *** p < 0.001; Student’s t test.

    Article Snippet: NR2C2 ( NM_003298 ) Human Tagged ORF Clone , Origene , Cat# RC219184.

    Techniques: Labeling, Control, Binding Assay, Transfection, Construct, Expressing, Western Blot, Quantitative RT-PCR, Plasmid Preparation, Mutagenesis, RNA Immunoprecipitation, CCK-8 Assay, Knock-Out, Cloning, Over Expression

    (A) SUnSET analysis of global translation levels across no As, Chr As, and As-Tr cells. (B) SUnSET analysis of global translation levels across HaCaT cells with ALKBH1 knockdown with or without arsenic treatment (200 nM, 72 h). (C) SUnSET analysis of global translation levels in As-Tr cells with ALKBH1 knockdown. (D) SUnSET analysis of global translation levels in shALKBH1 #1 As-Tr cells transfected with control or NR2C2 siRNA. (E) Immunoblot analysis of p-4EBP1 and 4EBP1 (total) in As-Tr cells with ALKBH1 knockdown. (F) Log2 fold change of SESN1 , SESN2 , and SESN3 mRNA expression in shALKBH1 #1 As-Tr cells as compared to shNC. Data taken from RNA-sequencing used as input for m 6 A-IP-sequencing. (G–I) IGV visualization of NR2C2 binding on SESN1 , SESN2 , and SESN3 transcripts taken from NR2C2 ChIP-seq data (ENCSR454GVT, ENCSR750LYM, ENCSR559ZKI) from ENCODE. (J) Immunoblot analysis of SESN1 and ALKBH1 expression in shNC and shALKBH1 #1 As-Tr cells. (K) Immunoblot analysis of p-4EBP1, 4EBP1 (total), SESN1, and NR2C2 expression in shALKBH1 #1 As-Tr cells with or without NR2C2 knockout. **** p < 0.0001; Student’s t test.

    Journal: Cell reports

    Article Title: Arsenic regulates ALKBH1 abundance and substrate specificity to promote translation and tumorigenicity

    doi: 10.1016/j.celrep.2025.116311

    Figure Lengend Snippet: (A) SUnSET analysis of global translation levels across no As, Chr As, and As-Tr cells. (B) SUnSET analysis of global translation levels across HaCaT cells with ALKBH1 knockdown with or without arsenic treatment (200 nM, 72 h). (C) SUnSET analysis of global translation levels in As-Tr cells with ALKBH1 knockdown. (D) SUnSET analysis of global translation levels in shALKBH1 #1 As-Tr cells transfected with control or NR2C2 siRNA. (E) Immunoblot analysis of p-4EBP1 and 4EBP1 (total) in As-Tr cells with ALKBH1 knockdown. (F) Log2 fold change of SESN1 , SESN2 , and SESN3 mRNA expression in shALKBH1 #1 As-Tr cells as compared to shNC. Data taken from RNA-sequencing used as input for m 6 A-IP-sequencing. (G–I) IGV visualization of NR2C2 binding on SESN1 , SESN2 , and SESN3 transcripts taken from NR2C2 ChIP-seq data (ENCSR454GVT, ENCSR750LYM, ENCSR559ZKI) from ENCODE. (J) Immunoblot analysis of SESN1 and ALKBH1 expression in shNC and shALKBH1 #1 As-Tr cells. (K) Immunoblot analysis of p-4EBP1, 4EBP1 (total), SESN1, and NR2C2 expression in shALKBH1 #1 As-Tr cells with or without NR2C2 knockout. **** p < 0.0001; Student’s t test.

    Article Snippet: NR2C2 ( NM_003298 ) Human Tagged ORF Clone , Origene , Cat# RC219184.

    Techniques: Knockdown, Transfection, Control, Western Blot, Expressing, RNA Sequencing, Sequencing, Binding Assay, ChIP-sequencing, Knock-Out